Inventor · disambiguated record
Mehdi Michel Djamel Numa
Also filed as: NUMA MEHDI · NUMA MEHDI MICHEL DJAMEL · NUMA MEHDI MICHEL JAMEL
33 granted patents·16 pending applications·1,759 citations·filing 2007–2024
98Inventor score
Files withVERTEX PHARMA33BINCH HAYLEY3RUAH SARA S HADIDA3ADARX PHARMACEUTICALS INC2OSPREY BIOPHARMACEUTICALS INC2
Top patents by PatentIndex Score
49 records- 0199US10239867B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2017·Granted Mar 26, 2019·26 cites·12 claims
- 0299US10022352B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2016·Granted Jul 17, 2018·30 cites·20 claims
- 0399US9758510B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2016·Granted Sep 12, 2017·36 cites·3 claims
- 0499US8952049B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Feb 10, 2015·62 cites·3 claims
- 0599US8912199B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Dec 16, 2014·65 cites·17 claims
- 0699US7645789B2Indole derivatives as CFTR modulatorsVERTEX PHARMA·Filed 2007·Granted Jan 12, 2010·171 cites·3 claims
- 0798US11639347B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2021·Granted May 2, 2023·5 cites·11 claims
- 0898US10987348B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2018·Granted Apr 27, 2021·13 cites·6 claims
- 0998US10975061B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·13 cites·12 claims
- 1098US9974781B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2016·Granted May 22, 2018·30 cites·3 claims
- 1198US8969382B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Mar 3, 2015·66 cites·10 claims
- 1298US8952050B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Feb 10, 2015·62 cites·23 claims
- 1398US8785640B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 22, 2014·72 cites·35 claims
- 1498US8623905B2Modulators of ATP-binding cassette transportersRUAH SARA S HADIDA·Filed 2010·Granted Jan 7, 2014·71 cites·57 claims
- 1598US8604203B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Dec 10, 2013·73 cites·35 claims
- 1698US8598205B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2012·Granted Dec 3, 2013·77 cites·22 claims
- 1798US8598181B2Modulators of ATP-binding cassette transportersHADIDA RUAH SARA S·Filed 2010·Granted Dec 3, 2013·71 cites·19 claims
- 1898US8575209B2Modulators of ATP-binding cassette transportersRUAH SARA S HADIDA·Filed 2010·Granted Nov 5, 2013·71 cites·20 claims
- 1998US8513282B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2009·Granted Aug 20, 2013·84 cites·11 claims
- 2098US8415387B2Modulators of ATP-binding cassette transportersRUAH SARA S HADIDA·Filed 2009·Granted Apr 9, 2013·83 cites·3 claims
- 2198US8314239B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2009·Granted Nov 20, 2012·100 cites·24 claims
- 2298US7776905B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2007·Granted Aug 17, 2010·145 cites·24 claims
- 2397US8884018B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Nov 11, 2014·62 cites·7 claims
- 2497US8754222B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Jun 17, 2014·66 cites·14 claims
- 2597US8614327B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2012·Granted Dec 24, 2013·78 cites·9 claims
- 2697US8344147B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2010·Granted Jan 1, 2013·90 cites·24 claims
- 2794US7846954B2Heterocyclic derivatives as modulators of ion channelsVERTEX PHARMA·Filed 2009·Granted Dec 7, 2010·27 cites·25 claims
- 2885US2024092766A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2983US7994166B2Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of painVERTEX PHARMA·Filed 2008·Granted Aug 9, 2011·4 cites·26 claims
- 3082US2023127655A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3179US2023100634A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3276US8343763B2Heterocyclic derivatives as modulators of ion channelsVERTEX PHARMA·Filed 2012·Granted Jan 1, 2013·2 cites·4 claims
- 3375US2015119441A1Modulators of ATP-Binding Cassette TransportersVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3473USRE50453EIndole derivatives as CFTR modulatorsVERTEX PHARMA·Filed 2022·Granted Jun 10, 2025·0 cites·3 claims
- 3572US8097636B2Heterocyclic derivatives as modulators of ion channelsSTAMOS DEAN·Filed 2008·Granted Jan 17, 2012·2 cites·25 claims
- 3670US8143297B2Heterocyclic derivatives as modulators of ion channelsHILGRAF NICOLE·Filed 2010·Granted Mar 27, 2012·2 cites·6 claims
- 3770US2015174098A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3870US2015094304A1Modulators of ATP-Binding Cassette TransportersVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3967US2025127904A1Siglec ligands, conjugates, and methods of use thereofOSPREY BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4066US2025064941A1Siglec ligands, conjugates, and methods of use thereofOSPREY BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4162US2014303204A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 4261US2014336393A1Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 4360US8841282B2Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channelsVERTEX PHARMA·Filed 2013·Granted Sep 23, 2014·0 cites·26 claims
- 4456US2025312367A1Oligonucleotides having a synthetic backbone and synthesis thereofADARX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4554US2014343098A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 4651US2014171427A1Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2013·Application pending·0 cites
- 4750US2024083934A1N-acetylgalactosamine (galnac)-derived compounds and oligonucleotidesADARX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4848US2012010416A1Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of painSTAMOS DEAN·Filed 2011·Application pending·0 cites
- 4937US2022144826A1Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related DisordersCOLLABORATIVE MEDICINAL DEV LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mehdi Michel Djamel Numa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →